Research summaries for everyoneNot medical advice
Epitalon research reference vial, Elevated Pharma

Research reference · Longevity & Immunity

Epitalon

Epitalon (also spelled epithalon) is a synthetic tetrapeptide, Ala-Glu-Asp-Gly, studied in aging models. Most of its literature comes from one Russian research network.

Published by Elevated Pharma ·

Longevity & ImmunityPreclinical literature

Identity

What is Epitalon?

A synthetic tetrapeptide modeled on the pineal extract epithalamin.

Research context

What has Epitalon been studied for?

Work covers telomerase activity in cell lines, animal aging and cancer models, and small Russian human studies. A 2025 independent study replicated telomere effects in human cell lines.

Evidence boundary

What does the research not show?

Cell and animal findings do not establish human longevity or clinical benefit.

U.S. status · November 7, 2026

Is Epitalon FDA-approved?

FDA removed it from its Category 2 compounding list in April 2026, and FDA’s compounding advisory committee recommended it for the 503A bulks list on July 24, 2026 (recommended). On October 28, 2026, HHS issued an interim policy saying it will not take enforcement action against licensed pharmacies and physicians that compound it under listed conditions, such as FDA-registered sourcing, a certificate of analysis and safety reporting. It is not FDA-approved, and the policy does not cover research-use-only material.

Research updates

What’s new

Dated developments for Epitalon, newest first. See all research updates.

  1. HHS interim compounding policy

    HHS published an enforcement-discretion policy covering BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500 for licensed pharmacies and physicians. Comments close November 13, 2026.

    Read the source
  2. FDA advisory committee votes

    FDA’s Pharmacy Compounding Advisory Committee voted on seven peptides over July 23–24, recommending six and declining emideltide (DSIP).

    Read the source

Key studies

The main Epitalon research

Selected from PubMed: human trials first, then reviews, then foundational laboratory work. Each finding applies to the material and setting studied.

Search all 141 PubMed records for Epitalon · Counts and selections checked November 7, 2026.

Reference identifiers

Epitalon identity data

Database identity describes the reference substance, not any specific material or lot.

Primary name
Epitalon
Also indexed as
Epithalon / Ala-Glu-Asp-Gly
Sequence
Ala-Glu-Asp-Gly
Molecular formula
C14H22N4O9
Molecular mass
390.35 g/mol
PubChem CID
219042

Official & primary sources

Regulatory and database records

Citation does not imply an Elevated Pharma partnership or endorsement.